Arcturus Therapeutics

Arcturus Therapeutics News & Events

SEC Filing Details

Document Details

Form
Filing Date
Aug 12, 2020
Document Date
Aug 10, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Arcturus Therapeutics, Inc.
Issuer
Arcturus Therapeutics Holdings Inc.
Filer
KURATA LANCE